Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection

Petta S, Camma C, di Marco V, et al. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Alessi N, Cabibi D, Caldarella R, Licata A, Massenti F, Tarantino G, et al. Am J Gastroenterol. 2008;103(5):1136-1144.

Publication Type:

Journal Article

Authors:

Petta, S.; Camma, C.; V di Marco; et, al

Source:

Am J Gastroenterol, Volume 103, Issue 5, p.1136-1144 (2008)

Keywords:

Affect, analysis, Biopsy, blood, Cholesterol, Cohort Studies, Cross-Sectional Studies, Diabetes Mellitus,Type 2, epidemiology, Fatty Liver, Fibrosis, genetics, Genotype, genotype 1, HCV, Hepacivirus, hepatitis, Hepatitis C, Hepatitis C,Chronic, Homeostasis, Humans, Infection, Insulin, Insulin Resistance, Italy, Liver, Liver Cirrhosis, Liver Function Tests, methods, Multivariate Analysis, Odds Ratio, pathology, Patients, physiology, Prevalence, Prognosis, resistance, Risk Factors, Rna, Rna,Viral, Role

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/18477344

Export Citation:

RIS Format

Top